• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病死亡率的预测因素。一项15年的随访研究。

Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study.

作者信息

Traver G A, Cline M G, Burrows B

出版信息

Am Rev Respir Dis. 1979 Jun;119(6):895-902. doi: 10.1164/arrd.1979.119.6.895.

DOI:10.1164/arrd.1979.119.6.895
PMID:453709
Abstract

The relative usefulness of various initial findings in predicting survival is reported for 200 patients with chronic obstructive pulmonary disease who have been followed for approximately 15 years. After 5 years of follow-up, subjects 62 or more years of age showed a poorer survival rate than younger subjects. After controlling for age, the per cent predicted forced expiratory volume in 1 sec after administration of bronchodilator was the best indicator of prognosis. In subjects less than 65 years of age, the presence or absence of cor pulmonale further improved the prediction of subsequent mortality. Regardless of initial findings, however, there was wide individual variability in prognosis, and factors relating to this variability remain obscure. No difference in survival rate was noted between the 178 male patients who were enrolled in Chicago 15 years ago and the 100 similarly impaired men enrolled in Tucson approximately 7 years ago.

摘要

报告了对200例慢性阻塞性肺疾病患者进行约15年随访后,各种初始检查结果在预测生存率方面的相对有用性。随访5年后,62岁及以上的受试者生存率低于年轻受试者。在控制年龄后,使用支气管扩张剂后1秒用力呼气量的预测百分比是预后的最佳指标。在65岁以下的受试者中,肺心病的有无进一步改善了对后续死亡率的预测。然而,无论初始检查结果如何,预后存在很大的个体差异,与这种差异相关的因素仍不清楚。15年前在芝加哥入组的178名男性患者与约7年前在图森入组的100名情况类似的男性患者之间,生存率没有差异。

相似文献

1
Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study.慢性阻塞性肺疾病死亡率的预测因素。一项15年的随访研究。
Am Rev Respir Dis. 1979 Jun;119(6):895-902. doi: 10.1164/arrd.1979.119.6.895.
2
Prognosis in severe chronic obstructive pulmonary disease.
Am Rev Respir Dis. 1979 Mar;119(3):357-67. doi: 10.1164/arrd.1979.119.3.357.
3
The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago "COPD" series.亚利桑那州普通人群样本中不同类型慢性气流受限的病程及预后:与芝加哥“慢性阻塞性肺疾病”系列研究的比较
Am Rev Respir Dis. 1989 Sep;140(3 Pt 2):S92-4. doi: 10.1164/ajrccm/140.3_Pt_2.S92.
4
[Prognostic parameters for cor pulmonale in chronic obstructive respiratory tract diseases].
Verh Dtsch Ges Inn Med. 1990;96:413-9.
5
[Physiopathology of chronic cor pulmonale. Has the subject been resolved?].[慢性肺源性心脏病的病理生理学。该问题已解决了吗?]
Arq Bras Cardiol. 1978 Aug;31(4):233-7.
6
Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.可逆性和不可逆性气流阻塞作为哮喘和慢性阻塞性肺疾病总体死亡率的预测指标
Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1267-71. doi: 10.1164/ajrccm.159.4.9807121.
7
Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility.评估通气变量对慢性气流阻塞患者生存预测的作用:可逆性的重要性
Eur J Respir Dis. 1985 Nov;67(5):360-8.
8
Prognosis in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的预后
Am Rev Respir Dis. 1986 Jan;133(1):14-20. doi: 10.1164/arrd.1986.133.1.14.
9
Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.作为哮喘和慢性阻塞性肺疾病总体死亡率预测指标的呼气峰值流速
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):690-3. doi: 10.1164/ajrccm.163.3.2006120.
10
[The hemodynamic changes in the course of the development from chronic obstructive pulmonary disease to cor pulmonale].[从慢性阻塞性肺疾病发展至肺源性心脏病过程中的血流动力学变化]
Zhonghua Jie He He Hu Xi Za Zhi. 1991 Apr;14(2):93-5, 127.

引用本文的文献

1
New spirometry recommendations from the Brazilian Thoracic Association - 2024 update.巴西胸科协会的新肺量计建议——2024年更新版。
J Bras Pneumol. 2025 Jan 20;50(6):e20240169. doi: 10.36416/1806-3756/e20240169. eCollection 2025.
2
Impact of Hyponatraemia at Clinical Stable-State on Survival in Patients with Chronic Obstructive Pulmonary Disease.临床稳定状态下低钠血症对慢性阻塞性肺疾病患者生存的影响
Int J Chron Obstruct Pulmon Dis. 2025 Jan 15;20:127-135. doi: 10.2147/COPD.S488309. eCollection 2025.
3
Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy.
真实世界中三联疗法治疗慢性阻塞性肺疾病的经验。
Int J Chron Obstruct Pulmon Dis. 2023 Jun 7;18:1057-1066. doi: 10.2147/COPD.S404039. eCollection 2023.
4
High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study.高流量鼻导管氧疗在 COPD 住院患者中的应用:一项回顾性队列研究。
PLoS One. 2022 Oct 5;17(10):e0272372. doi: 10.1371/journal.pone.0272372. eCollection 2022.
5
Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease.弥散量与慢性阻塞性肺疾病死亡率。
Ann Am Thorac Soc. 2023 Jan;20(1):38-46. doi: 10.1513/AnnalsATS.202203-226OC.
6
Lung transplantation for emphysema.肺气肿的肺移植
Ann Transl Med. 2020 Nov;8(21):1473. doi: 10.21037/atm-20-805.
7
How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?如何对稳定期慢性阻塞性肺疾病男性患者进行气流受限分级?
Am J Mens Health. 2020 May-Jun;14(3):1557988320922630. doi: 10.1177/1557988320922630.
8
Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPD.与终末期慢性阻塞性肺疾病患者的药物治疗和肺康复相比,肺移植的生存获益情况。
ERJ Open Res. 2020 Apr 27;6(2). doi: 10.1183/23120541.00177-2019. eCollection 2020 Apr.
9
Diffusing Capacity of Carbon Monoxide in Assessment of COPD.一氧化碳弥散量在 COPD 评估中的应用。
Chest. 2019 Dec;156(6):1111-1119. doi: 10.1016/j.chest.2019.06.035. Epub 2019 Jul 25.
10
COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power.慢性阻塞性肺疾病:意大利过去二十年的年度疾病成本及其死亡率预测能力。
Healthcare (Basel). 2019 Mar 1;7(1):35. doi: 10.3390/healthcare7010035.